Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
about
Systematic review and meta-analysis of lactose digestion, its impact on intolerance and nutritional effects of dairy food restriction in inflammatory bowel diseasesEfficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to dateIrritable bowel syndrome: new insights into symptom mechanisms and advances in treatmentOverlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?Diagnosis and management of functional symptoms in inflammatory bowel disease in remissionRole of environmental pollution in irritable bowel syndromeAntioxidant therapy for treatment of inflammatory bowel disease: Does it work?Interventions and targets aimed at improving quality in inflammatory bowel disease ambulatory careIrritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into placeSystematic review with meta-analysis: the prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoeaGetting personal: a review of sexual functioning, body image, and their impact on quality of life in patients with inflammatory bowel diseaseReview article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel diseaseIBS-like symptoms in patients with ulcerative colitisDiagnosis and management of microscopic colitis: current perspectivesThe analysis of factors associated with progression of isolated terminal ileal lesionsVisceral hypersensitivity in inflammatory bowel diseases and irritable bowel syndrome: The role of proteasesMechanisms and efficacy of dietary FODMAP restriction in IBS.Self-reported Symptom Burden in Individuals with Inflammatory Bowel Disease.Fermentable carbohydrates (FODMAPs) exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised, double-blind, placebo-controlled, cross-over, re-challenge trial.Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation.Mind-Body Interventions for Pediatric Inflammatory Bowel Disease.Low-FODMAP diet reduces irritable bowel symptoms in patients with inflammatory bowel diseasePsychological disorders in gastrointestinal disease: epiphenomenon, cause or consequence?Molecular mechanisms by which casein glycomacropeptide maintains internal homeostasis in mice with experimental ulcerative colitis.Tricyclic antidepressants for management of residual symptoms in inflammatory bowel disease.Irritable bowel syndrome: current and emerging treatment options.Follow-up of patients with functional bowel symptoms treated with a low FODMAP diet.Relationship between the exocrine and endocrine pancreas after acute pancreatitis.Association between the location of diverticular disease and the irritable bowel syndrome: a multicenter study in JapanCan fecal calprotectin better stratify Crohn's disease activity index?Predictors of abdominal pain in depressed pediatric inflammatory bowel disease patientsFaecalibacterium prausnitzii prevents physiological damages in a chronic low-grade inflammation murine model.Development and validation of a biomarker for diarrhea-predominant irritable bowel syndrome in human subjects.Increased serum levels of lipopolysaccharide and antiflagellin antibodies in patients with diarrhea-predominant irritable bowel syndrome.Behavioral and molecular processing of visceral pain in the brain of mice: impact of colitis and psychological stressCommon Mechanism of Pathogenesis in Gastrointestinal Diseases Implied by Consistent Efficacy of Single Chinese Medicine Formula: A PRISMA-Compliant Systematic Review and Meta-AnalysisIBS and IBD - separate entities or on a spectrum?Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.A Pooled Analysis of Efficacy, Safety, and Long-term Outcome of Endoscopic Balloon Dilation Therapy for Patients with Stricturing Crohn's Disease.Advances in IBS 2016: A Review of Current and Emerging Data.
P2860
Q26740495-41B4C511-075B-49D5-BF45-872FEB5106AAQ26744329-09CA7887-2959-43F3-A501-70583E6B3630Q26751193-BD23C59A-A294-4363-A116-4E06BEFBB831Q26765219-C37CABAD-3BC0-42A8-9819-FCB3A21C1F19Q26768264-1CBB1ACC-3803-4947-955A-080A3763020CQ26777544-12539FFC-C77C-4EAE-B75F-17D5BA625637Q26777641-9509803B-CC55-4A3A-800A-85704D061664Q26823569-93AC18D7-6DB8-4C82-94A5-BF8558837768Q28071496-20BD9B5A-3D0A-4B86-904F-F375EF1B955AQ28081213-CF3B1A50-E22E-4E84-93B1-E1ABAF963A3CQ28081954-39F63442-5EA2-4455-93B8-E7ED4D008401Q28083764-81511F93-05DD-44AA-90BD-17CD69C1E673Q28088663-8BB2B0A3-4CC4-4F62-B410-3B388605BBEEQ28246941-A4CACABA-AEE3-4AA8-A560-E6F38088EE0CQ28540843-7594447E-AD2D-4E2C-B0B5-F9E80FC5527AQ28818844-F621756A-C680-457F-82D6-CEC1F0C7F752Q30738587-8E0986FB-6CD8-47BA-ABC7-DABEFE0F1CC7Q33466601-522BC884-A0F3-490B-B7E9-57388E571AEFQ33470528-1A991744-CC92-426D-9CEA-66045DE72316Q33578069-4232AB17-4AA9-4452-BEF4-2E80406CF89BQ33607860-15DCDCCE-FF46-4042-8CB4-165FE848D05BQ33696448-853931E9-D479-4974-8E24-3EEDB9EEE6A0Q33813422-AF05F1F0-B5BC-4B71-BE4D-62D73AD983E5Q33897813-E2E1BF79-1D4C-4CDB-B4D7-0A1D6B54DCA4Q33951233-1252BD54-75F8-4BAA-9CB9-7A35056A86F3Q34010550-AC0177DA-4454-40EB-94B0-8D3C5201C89AQ34522949-20B4D2D3-7220-43AB-898C-17ACA384C01AQ34647744-9364895A-18A9-4D52-91CB-27DB53230374Q34664668-12E236A6-C2F9-4210-A99A-F70291B75A69Q35199260-54484424-166E-4AA2-AE6F-39DC22E27236Q35204510-2C3F9753-4095-4C30-9DDD-467D401C5EAFQ35336737-F9EDB33D-3342-457E-8B31-5CA3CE282F7AQ35603014-04C7EEF6-C965-4242-A436-941AD47C766AQ35781494-2F65C527-974D-4C80-A57A-CA8835416D4DQ35837295-9C777025-3B02-4EF5-9B54-E36387CF6999Q35857980-DA8A451F-64E6-46FB-A084-F3674FCC290DQ36144375-B401E9E4-66E5-431E-865E-96A23D33EDC4Q36202746-A246CF0F-A4E0-48D8-B137-AD4FCBBE2D5BQ36230325-6E00AAE5-B56B-4C82-A8EF-05AB30F87ED7Q36245061-C0E1C409-18F0-4535-A605-8834306C66A5
P2860
Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Prevalence of symptoms meeting ...... atic review and meta-analysis.
@en
Prevalence of symptoms meeting ...... atic review and meta-analysis.
@en-gb
type
label
Prevalence of symptoms meeting ...... atic review and meta-analysis.
@en
Prevalence of symptoms meeting ...... atic review and meta-analysis.
@en-gb
prefLabel
Prevalence of symptoms meeting ...... atic review and meta-analysis.
@en
Prevalence of symptoms meeting ...... atic review and meta-analysis.
@en-gb
P921
P356
P1476
Prevalence of symptoms meeting ...... atic review and meta-analysis.
@en
P2093
Stephen J Halpin
P304
P356
10.1038/AJG.2012.260
P407
P577
2012-08-28T00:00:00Z